Nonoperating Income (Expense) in USD of Autolus Therapeutics plc from 2016 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Autolus Therapeutics plc quarterly/annual Nonoperating Income (Expense) history and change rate from 2016 to Q3 2025.
  • Autolus Therapeutics plc Nonoperating Income (Expense) for the quarter ending 30 Sep 2025 was -$6.97M, a 50.9% increase year-over-year.
  • Autolus Therapeutics plc Nonoperating Income (Expense) for the twelve months ending 30 Sep 2025 was $53.8M.
  • Autolus Therapeutics plc annual Nonoperating Income (Expense) for 2024 was $22.3M.
  • Autolus Therapeutics plc annual Nonoperating Income (Expense) for 2023 was -$28.7M, a 456% decline from 2022.
  • Autolus Therapeutics plc annual Nonoperating Income (Expense) for 2022 was -$5.16M, a 422% decline from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

Autolus Therapeutics plc Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $53.8M -$6.97M +$7.23M +50.9% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025
Q2 2025 $46.5M $13.7M +$13M +1835% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025
Q1 2025 $33.5M -$2.7M +$11.2M +80.7% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q4 2024 $22.3M $49.7M +$73.6M 01 Oct 2024 31 Dec 2024 10-K 20 Mar 2025
Q3 2024 -$51.4M -$14.2M -$11.2M -379% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025
Q2 2024 -$40.1M $708K +$1.84M 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025
Q1 2024 -$42M -$13.9M -$13.3M -1959% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q4 2023 -$28.7M -$23.9M -$28.1M -667% 01 Oct 2023 31 Dec 2023 10-K 20 Mar 2025
Q3 2023 -$557K -$2.97M +$2.46M +45.3% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 -$3.02M -$1.14M +$1.92M +62.8% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 -$4.93M -$677K +$225K +24.9% 01 Jan 2023 31 Mar 2023 10-Q 17 May 2024
Q4 2022 -$5.16M $4.22M 01 Oct 2022 31 Dec 2022 10-K 21 Mar 2024
Q3 2022 -$5.43M 01 Jul 2022 30 Sep 2022 10-K 21 Mar 2024
Q2 2022 -$3.05M 01 Apr 2022 30 Jun 2022 10-K 21 Mar 2024
Q1 2022 -$902K -$1.78M -202% 01 Jan 2022 31 Mar 2022 10-K 21 Mar 2024
Q1 2021 -$2.22M $882K -$4.11M -82.3% 01 Jan 2021 31 Mar 2021 6-K 06 May 2021
Q4 2020 $1.89M -$1.11M +$614K +35.6% 01 Oct 2020 31 Dec 2020 20-F 07 Mar 2023
Q3 2020 $1.27M -$2.47M -$6.24M -166% 01 Jul 2020 30 Sep 2020 6-K 05 Nov 2020
Q2 2020 $7.52M $478K -$4.98M -91.2% 01 Apr 2020 30 Jun 2020 6-K 06 Aug 2020
Q1 2020 $12.5M $4.99M +$5.44M 01 Jan 2020 31 Mar 2020 6-K 06 May 2021
Q4 2019 $7.06M -$1.73M -$3.48M -198% 01 Oct 2019 31 Dec 2019 20-F 10 Mar 2022
Q3 2019 $10.5M $3.77M +$1.77M +88.4% 01 Jul 2019 30 Sep 2019 6-K 05 Nov 2020
Q2 2019 $8.77M $5.45M -$1.2M -18.1% 01 Apr 2019 30 Jun 2019 6-K 06 Aug 2020
Q1 2019 $9.97M -$443K 01 Jan 2019 31 Mar 2019 6-K 07 May 2020
Q4 2018 $1.76M +$2.26M 01 Oct 2018 31 Dec 2018 20-F 04 Mar 2021
Q3 2018 $2M 01 Jul 2018 30 Sep 2018 6-K 07 Nov 2019
Q2 2018 $6.66M 01 Apr 2018 30 Jun 2018 6-K 08 Aug 2019
Q4 2017 -$504K 01 Oct 2017 31 Dec 2017 20-F 25 Feb 2019

Autolus Therapeutics plc Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $22.3M +$51M 01 Jan 2024 31 Dec 2024 10-K 20 Mar 2025
2023 -$28.7M -$23.5M -456% 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2025
2022 -$5.16M -$4.17M -422% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024
2021 -$988K -$2.88M -152% 01 Jan 2021 31 Dec 2021 10-K 21 Mar 2024
2020 $1.89M -$5.17M -73.2% 01 Jan 2020 31 Dec 2020 20-F 07 Mar 2023
2019 $7.06M +$1.55M +28.2% 01 Jan 2019 31 Dec 2019 20-F 10 Mar 2022
2018 $5.5M +$5.46M +14379% 01 Oct 2017 30 Sep 2018 20-F 03 Mar 2020
2017 $38K -$11K -22.4% 01 Oct 2016 30 Sep 2017 20-F 03 Mar 2020
2016 $49K 01 Oct 2015 30 Sep 2016 20-F 25 Feb 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.